Epilepsy patients have a higher
reported incidence of depressive
disorders than the general
population, according to this week’s
RGH Pharmacy E-Bulletin.
Possible rationales for this
increased prevalence are developed
in the bulletin along with issues
around proconvulsive potential
and pharmacokinetic interactions
associated with selective serotonin
re-uptake inhibitors and other
antidepressants.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Aug 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.